Next 10 |
Flex Pharma, Inc. (Nasdaq: FLKS) announced that its Board of Directors today declared a special dividend on the Company’s common stock of one right per share of outstanding common stock. The rights will be paid on July 19, 2019 to shareholders of record as of close of business on July ...
At its special meeting, Flex Pharma (NASDAQ: FLKS ) stockholders voted in favor of all merger-related proposals associated with its planned tie-up with Salarius Pharmaceuticals announced in January. The transaction should close in the coming weeks. More news on: Flex Ltd., Flex Ph...
Flex Pharma, Inc. (Nasdaq: FLKS) today announced that its stockholders approved all proposals relating to its planned merger with Salarius Pharmaceuticals, LLC at Flex Pharma’s special meeting of stockholders. Flex Pharma will file a Form 8-K to disclose detailed voting results for eac...
Flex Pharma, Inc. (Nasdaq: FLKS) today announced that on or about June 27, 2019 it will mail a supplement (the “Supplement”) to its proxy materials to provide stockholders with updated information regarding brokers’ discretionary authority to vote stockholders’ sha...
Flex Pharma (NASDAQ: FLKS ) announces that approx. 85% of shares voted to date support the proposed merger with Salarius Pharmaceuticals. More news on: Flex Pharma, Inc., Healthcare stocks news, Read more ...
- Special Meeting of Stockholders Adjourned Until July 12, 2019 Flex Pharma, Inc. (Nasdaq: FLKS) today announced that approximately 85% of shares voted to date support the proposed merger with Salarius Pharmaceuticals, LLC, an epigenetic oncology company. However, in order to comple...
Flex Pharma, Inc. (Nasdaq: FLKS) today announced that Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis recommend that shareholders vote FOR all agenda items before or at Flex Pharma’s June 14 Special Shareholders Meeting. Flex’s Board of Directors...
Flex Pharma (NASDAQ: FLKS ): Q1 GAAP EPS of -$0.12. More news on: Flex Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Flex Pharma, Inc. (NASDAQ: FLKS), today announced its financial results for the three months ended March 31, 2019. On January 3, 2019, Flex Pharma (the "Company") and Salarius Pharmaceuticals, LLC ("Salarius") entered into an Agreement and Plan of Merger (the "Merger Agreement") pursua...
Flex Pharma (NASDAQ: FLKS ): Q4 GAAP EPS of -$0.11. More news on: Flex Pharma, Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
FTSE Lujain Kuwait Shariah Index Company Name:
FLKS Stock Symbol:
NASDAQ Market:
FTSE Lujain Kuwait Shariah Index Website:
Flex Pharma, Inc. (Nasdaq: FLKS) announced that its Board of Directors today declared a special dividend on the Company’s common stock of one right per share of outstanding common stock. The rights will be paid on July 19, 2019 to shareholders of record as of close of business on July ...
Flex Pharma, Inc. (Nasdaq: FLKS) today announced that its stockholders approved all proposals relating to its planned merger with Salarius Pharmaceuticals, LLC at Flex Pharma’s special meeting of stockholders. Flex Pharma will file a Form 8-K to disclose detailed voting results for eac...
Flex Pharma, Inc. (Nasdaq: FLKS) today announced that on or about June 27, 2019 it will mail a supplement (the “Supplement”) to its proxy materials to provide stockholders with updated information regarding brokers’ discretionary authority to vote stockholders’ sha...